Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery

Circulation Journal

Volumn 72, Issue 9, 2008, Pages 1481-1486

  Kajimoto, Kan ^a   Kasai, Takatoshi ^a   Miyauchi, Katsumi ^a   Hirose, Hitoshi ^a   Yanagisawa, Naotake ^a   Yamamoto, Taira ^a   Takazawa, Kenji ^b   Niinami, Hiroshi ^a   Hosoda, Yasuyuki ^c   Daida, Hiroyuki ^a   Amano, Atsushi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b Social Insurance Chuo General Hospital   (Japan)

^c Kawasaki Saiwai Hospital   (Japan)

Author keywords

Coronary artery bypass grafting; Diabetes mellitus; Long term outcomes; Metabolic syndrome

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; FEMALE; HAZARD RATIO; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; WAIST CIRCUMFERENCE;

AGED; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 50449092200     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-07-0928     Document Type: Article

References (18)

1. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
2. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250.
3. Langenberg C, Bergstrom J, Scheidt-Nave C, Pfeilschifter J, Barrett-Connor E. Cardiovascular death and the metabolic syndrome: Role of adiposity-signaling hormones and inflammatory markers. Diabetes Care 2006; 29: 1363-1369.
4. Levantesi G, Macchia A, Marfisi R, Franzosi MG, Maggioni AP, Nicolosi GL, et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 2005; 46: 277-283.
5. Rana JS, Monraats PS, Zwinderman AH, de Maat MP, Kastelein JJ, Doevendans PA, et al. Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention. Diabetes Care 2005; 28: 873-877.
6. Nigam A, Bourassa MG, Fortier A, Guertin MC, Tardif JC. The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J 2006; 151: 514-521.
7. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
8. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.
9. Rajakaruna C, Rogers CA, Suranimala C, Angelini GD, Ascione R. The effect of diabetes mellitus on patients undergoing coronary surgery: A risk-adjusted analysis. J Thorac Cardiovasc Surg 2006; 132: 802-810.
10. Gao D, Grunwald GK, Rumsfeld JS, Schooley L, MacKenzie T, Shroyer AL. Time-varying risk factors for long-term mortality after coronary artery bypass graft surgery. Ann Thorac Surg 2006; 81: 793-799.
11. van de Wal RM, van Brussel BL, Voors AA, Smilde TD, Kelder JC, van Swieten HA, et al. Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery. J Thorac Cardiovasc Surg 2005; 129: 330-335.
12. Pan W, Hindler K, Lee VV, Vaughn WK, Collard CD. Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. Anesthesiology 2006; 104: 441-447.
13. Sabik JF 3rd, Blackstone EH, Gillinov AM, Banbury MK, Smedira NG, Lytle BW. Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg 2006; 131: 90 -98.
14. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation 1998; 97: 916-931.
15. Yilmaz MB, Guray Y, Guray U, Biyikoglu SF, Tandogan I, Korkmaz S. Metabolic syndrome negatively impacts early patency of saphenous vein grafts. Coron Artery Dis 2006; 17: 41-44.
16. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: Prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002; 25: 1135-1141.
17. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-436.
18. Ingelsson E, Arnlov J, Lind L, Sundstrom J. Metabolic syndrome and risk for heart failure in middle-aged men. Heart 2006; 92: 1409-1413.